Skip to main content
Clinical Trials/IRCT20210507051204N2
IRCT20210507051204N2
Not yet recruiting
未知

Investigating and comparing the effectiveness of a mindfulness-based intervention along with standard treatment compared to standard treatment alone on the food craving trait in overweight and obese individuals with mild to moderate anxiety and/or depression: a randomized controlled trial.

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Mild to moderate anxiety or depression: according to the DASS\-21 questionnaire, a score of 7 to 12 in men and 9 to 14 in women for the depression subscale, or a score of 6 to 11 in men and 8 to 12 in women for the anxiety subscale
  • Access to a smart phone and the ability to use it to receive and use the files related to study
  • Having sufficient literacy (reading and writing) to complete forms and questionnaires
  • Living in Isfahan city or nearby towns and villages
  • Willingness to participate in the study

Exclusion Criteria

  • Being a candidate for bariatric surgery
  • History of bariatric surgery in the last 18 months
  • Age less than 18 or more than 65 years
  • Having mental disabilities, blindness or deafness
  • Being treated in other centers or participating in other similar studies
  • Having a history of acute psychological diseases such as major depression, bulimia, anorexia, suicide or suicidal thoughts, schizophrenia, acute personality disorders, severe anxiety and depression, panic disorder and drug addiction.
  • History of hospitalization due to psychological diseases
  • History of diseases affecting appetite and weight gain/loss such as hypo/hyperthyroidism, liver cirrhosis, uncontrolled metabolic diseases, immune diseases and malignancy
  • Taking drugs that have a significant effect on metabolism or appetite, such as corticosteroids, psychiatric drugs, and hormonal drugs
  • Previous familiarity with and regular use of mindfulness\-based techniques (more than or equal to three times a week, each time 10 minutes or more)

Outcomes

Primary Outcomes

Not specified

Similar Trials